Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2022-05-13 00:00:00 ET · period of report 2022-05-12 · accession 0001808805-22-000056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-05-13 | 2022-05-12 | NAUT | Murphy Matthew B. | GC | A - Grant | $3.28 | +10.0K | 44.1K | +29% | +$32.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-12 | A | A | 10,000 | $3.28 | 44,140 | I See Footnote | — | — | (F1) Shares held by the Murphy Family Trust. The reporting person is the Trustee of the Murphy Family Trust. |